#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in intestine Vaginal cancer Piriformis syndrome Huntington's disease Anal cancer Cystic fibrosis gastrointestinal disease Richter's syndrome Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Hypersomnia Biotinidase deficiency Vascular malformation Demyelination Ovarian cancer stage III Mastocytosis Cardiac failure acute More trials…

    Learn about Rare Diseases

    Cholangitis sclerosing – Life with Disease Congenital nephrogenic diabetes insipidus – Life with Disease X-linked lymphoproliferative syndrome – Trials in Disease Brain stem glioma – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Factor IX deficiency – Trials in Disease Usher’s syndrome – Treatment Focal segmental glomerulosclerosis Mucopolysaccharidosis III Wiskott-Aldrich syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tezacaftor Myrrh LY4170156 Fedratinib Remibrutinib Ep262 Obexelimab Savolitinib Thalidomide Mianserin Hydrochloride Streptococcus Pneumoniae Tomligisiran Lsta1 Difelikefalin Eplerenone Iron Petosemtamab OXYBUTYNIN HYDROCHLORIDE Abc-31-116 Ly3871801 More therapies…

    Learn about Your Condition

    Glioblastoma multiforme Malabsorption Systemic scleroderma Dyspnoea Hot flush Combined immunodeficiency Body mass index increased Breast neoplasm Colorectal cancer stage II Congenital aplastic anaemia Hodgkin's disease refractory Hypocalcaemia Cardiac failure chronic Skin angiosarcoma Breast cancer male More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A Study Testing Propranolol for Patients with Traumatic Brain Injury Who Need Intensive Care Unit Treatment

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Craniocerebral injury
    Investigated Drugs:
    • Propranolol Hydrochloride
    Spain

  • A Study Using Indocyanine Green Fluorescence Imaging to Help Surgeons Better Identify Tumor Edges During Cancer Surgery in Patients with Solid Tumors

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    • Genitourinary tract neoplasm
    • Head and neck cancer
    Investigated Drugs:
    • Indocyanine Green
    The Netherlands

  • Study of 18F-FAPI-74 PET/CT Imaging to Detect Cancer Spread in Patients with Non-Small Cell Lung Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    Finland

  • A Study of Semaglutide for Diabetic Patients with Heart Attack or Unstable Angina to Measure Changes in Coronary Artery Plaque Using Imaging

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    • Diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Italy

  • Comparing 7-Day and 4-Week Esomeprazole Treatment in Patients with Unexplained Dyspepsia

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Dyspepsia
    Investigated Drugs:
    • MAGNESIUM CARBONATE HEAVY
    • Calcium Carbonate
    • Esomeprazole
    Iceland

  • Comparing Dapagliflozin and Tocilizumab for Treating Patients with Systemic Sclerosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Dapagliflozin
    • Sodium Chloride
    • Tocilizumab
    Poland
Previous Page
1 … 748 749 750 751 752 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!